Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Today's biggest point gainers/losers
Biggest point gainers:
NVRO (55.72 +10.36), ACT (302.45 +9.63), MNST (138.03 +9.56), NFLX (583.73 +9.13), CALM (48.70 +5.70), Z (97.69 +5.41), ROSE (24.31 +4.99), LGND (85.25 +4.74), ASGN (36.97 +4.13), TSLA (240.63 +4.02), GWPH (113.86 +3.95), RCPT (157.52 +3.66), HAR (132.34 +3.06), SEDG (34.12 +3.02), WHR (188.21 +2.56), CSIQ (39.57 +2.47), RDUS (40.29 +2.30), JOY (43.98 +1.95), PAYC (37.65 +1.95), KLXI (43.64 +1.74), CONN (34.55 +1.65), TASR (33.59 +1.65), EW (128.03 +1.63), CAT (88.89 +1.58), MBLY (47.33 +1.52)
Biggest point losers:
PXD (154.00 -5.06), TM (137.67 -4.45), NBL (45.69 -3.43), TSO (87.36 -3.12), CXO (115.27 -3.03), MPC (102.00 -2.88), BIIB (395.70 -2.73), QRVO (73.93 -2.63), ETSY (20.50 -2.21), HES (72.19 -2.15), GOOG (536.32 -1.91), HP (75.77 -1.89), WYNN (116.02 -1.82), HUBS (44.94 -1.81), MUR (44.83 -1.81), XEC (116.68 -1.76), VRTX (125.66 -1.75), RRC (62.55 -1.74), APC (86.86 -1.71), NOV (51.54 -1.69), TRV (102.04 -1.69), YELP (48.27 -1.66), CLR (46.74 -1.60), AAPL (126.08 -1.54), EOG (92.02 -1.48)
Very, very good story...I like it a lot, MG...
Gapping down
In reaction to disappointing earnings/guidance: FXCM -10.7%, NSPR -5.3%, PLUG -4.5%, FMC -4.4%, MGIC -4.1%, EVEP -3.3%, ARKR -1.7%, VRTS -1.5%, RBC -1.3%, FRM -1%, INO -0.7%
Other news: LACO -49.5% (disclosed conference call transcript from Thursday night; says merger with Sartini Gaming is anticipated to close later this year, possibly as early as August), FTR -7.7% (still checking), GEVO -7.5% (pulling back following Fridays advance), NBG -6.8% (reports IMF is making contingency plans for Greece default), GFI -4.9% (announced that a contractor at the South Deep project in South Africa lost his life in a tramming accident ), MGIC -4.1% (still checking), AKRX -2.9% (discloses a delay in filing form 10-Q), NXTD -1.8% (files for ~2.1 mln share common stock offering by selling shareholders), QGEN -1.4% (still checking), HLT -1.1% (secondary offering, by selling stockholders affiliated with the Blackstone Group (BX), for 90 mln shares of common stock), BBRY -1% (still checking), SUNE -0.7% (it and Wacker Chemie AG entered into a Settlement and Release Agreement)
Analyst comments: AMZG -32.5% (downgraded to Hold at Johnson Rice ), ETSY -8.9% (downgraded to Underperform from Neutral at Wedbush), TNK -4.3% (downgraded to Hold from Buy at Deutsche Bank), MNKD -2.1% (downgraded to Underweight from Neutral at JP Morgan), DYAX -1.6% (downgraded to Perform from Outperform at Oppenheimer), CRM -1.2% (removed from Best Ideas List at Morgan Stanley), HCLP -1% (downgraded to Neutral from Outperform at Credit Suisse), OUTR -0.8% (downgraded to Equal Weight from Overweight at First Analysis Sec)
Read more: http://www.briefing.com/GeneralContent/Platinum/Active/FullTextSearch/FullTextSearch.aspx#ixzz3ZpqbvaUs
Gapping up
In reaction to strong earnings/guidance: NVRO +35%, RNF +12.9%, RTK +9.3%, W +8.8%, KBIO +8%, CGA +7.7%, NES +5.2%, DF +5.2%, MBLY +2.8%, GORO +2.7%, TICC +2.7%, ACT +2.6%, ENDP +2.6%, GWPH +1.8%, BDSI +1.4%, AU +1.2%, KNDI +1.1%, SSYS +0.5%
M&A news: ROSE +32.8% (to be acquired by Noble Energy (NBL) in an all-stock transaction valued at $2.1 billion, or an implied value of $26.62/share), CBK +2.4% (Christopher & Banks considering sale of the company, according to NY Post), SYT +0.9% (Monsanto (MON) considering raising bid for SYT, according to Reuters; also upgraded to Buy from Neutral at UBS)
Select metals/mining stocks trading higher: SSRI +11.1%, RIO +2.6%, VALE +2.2%, GOLD +0.9%, BHP +0.9%
Other news: CALI +38.8% (China stocks strong overnight after PBOC rate cut), ZU +20.9% (Alibaba (BABA) disclosed Friday night in a Form 4 filing that it purchased 11.5 mln shares of ZU), CANF +15.1% (announces it recently received clearance from the EMA to commence dosing patients in Europe in its global Phase II trial for CF102 in the treatment of hepatocellular carcinoma), MYOS +12.7% (announces the initiation of a dose response clinical study of Fortetropin), RXII +6.3% (announces new data for self-delivering RNAi compounds), SFUN +4.3% (China stocks strong overnight after PBOC rate cut), GIGM +3.8% (announces that CFO Dirk Chen has resigned for personal reasons; also reported earnings), TOUR +2.6% (appoints COO Alex Yan as President), ENDP +2.5% (acquires a portfolio of branded and generic injectable products focused on pain, anti-infectives and cardiovascular applications from Aspen Holdings for $130 mln)
Analyst comments: ADRO +4.9% (initiated with a Outperform at Leerink Partners; initiated with a Buy at BofA/Merrill), Z +3.6% (upgraded to Buy from Neutral at Sun Trust Rbsn Humphrey), GDDY +2.8% (initiated with a Overweight at JP Morgan, among others), CDTX +2.1% (initiated with a Outperform at Wedbush), WWWW +1.8% (upgraded to Buy from Hold at Deutsche Bank ), MNST +1.6% (upgraded to Buy from Neutral at Citigroup), SFM +1.2% (upgraded to Outperform from Market Perform at BMO Capital), CSCO +1.2% (upgraded to Outperform from Sector Perform at Pacific Crest), CAT +0.8% (upgraded to Outperform from Neutral at Robert W. Baird), JOY +0.8% (upgraded to Outperform from Neutral at Robert W. Baird), SBH +0.8% (upgraded to Outperform from Mkt Perform at Raymond James), NOK +0.7% (upgraded to Outperform from Neutral at Exane BNP Paribas)
Read more: http://www.briefing.com/GeneralContent/Platinum/Active/FullTextSearch/FullTextSearch.aspx#ixzz3ZpqJ9q6x
Hope everyone had a Happy Mother's Day...
Earnings Preview for the week of May 11 - 15
Of the companies reporting earnings for the week of May 11 - 15 some of the bigger names include:
Monday:
Pre Market - AES, ACT, DISH, CNP, DF, AER, RBC, ENDP, BRSS, W, SSYS, RDNT, BID, STRL, FRM, VRTS, CRK, EVEP, MHR, MBLY, MGIC, PLUG, LGND, GWPH, ICPT
After Hours - MTZ, MDR, FMC, DPLO, SF, RAX, DRYS, PRSC, EGL, TRQ, HI, ORIG, TTEC, MR, PINC, SCAI, PEIX, MBI, PAHC, PAAS, YY, IPXL, TEP, VRTU, IPAR, CALL, JUNO
Tuesday:
Pre Market - ACM, ECA, LDOS, ARCO, IFF, FMSA, ARES, WMS, ATRO, IBP, CRCM, DCIX, OTIV, NAVB, EGRX
After Hours - MCK, STKL, HMIN, DCO, Z, SSRI, LMNS, PE, RSPP, EXAR, ESIO, OPWR, PRSS, NEWR, INGN, TUBE, FIVN, NVMI, HDP, VSLR, CDNA, CARA, VTAE, VTL, RENN, ZFGN
Wednesday:
Pre Market - M, ARMK, PCP, RL, IGT, ZBRA, ZAYO, MRKT, ACAT, ELOS, SHLX, DSX, EZCH, MTLS, CRME
After Hours - CSCO, JCP, VIPS, RNDY, NTES, JACK, VOXX, WX, LXFT, SPKE, TGB, FENG, AMPH, SHAK, FPRX
Thursday:
Pre Market - KSS, QIWI, CSTM, VWR, GIL, TK, PLCE, PERY, PBH, HIMX, TNK, MANU, STOR, MMYT, PFNX, HSGX
After Hours - JWN, AMAT, SYMC, HTHT, DAR, KING, EXP, ANET, LOCO, GLOB, SANW, MDLY, UPLD, VCYT, JYNT
Friday:
Pre Market - HGG, OCUL, JMG
Notable movers of interest
The following are some of today's most notable movers of interest, categorized by market capitalization (large cap over $10 billion and mid cap between $2-10 billion) and ranked by % change (all stocks over 100K average daily volume).
Large Cap Gainers
SYT (85.32 +10.81%): Confirmed it received an unsolicited takeover proposal from Monsanto (MON), which it unanimously determined to reject.
RBS (10.95 +7.35%): British banks outperforming following strength in the FTSE exchange after the U.K elections (LYG, BCS also higher).
ALU (3.8 +4.31%): Upgraded to Buy at Societe Generale, upgraded to Buy at UBS.
Large Cap Losers
MNST (129.77 -9.56%): Reported Q1 (Mar) earnings of $0.62 per share, $0.06 worse than the Capital IQ Consensus Estimate of $0.68; revenues rose 16.9% year/year to $626.79 mln vs the $596.82 mln consensus; downgraded to Neutral from Buy at Goldman an removed from Americas Conviction Buy List.
NVDA (20.64 -8.23%): Reported Q1 EPS in-line, revs in-line; guided Q2 revs below consensus; Downgraded at ROTH Capital.
CERN (68.01 -4.55%): Reported Q1 EPS in-line, missed on revs; guided Q2 EPS in-line, revs below consensus; raised low end of FY15 EPS; lowered rev below consensus.
Mid Cap Gainers
DATA (111.76 +14.71%): Beat Q1 consensus EPS estimates by $0.11, beat on revs, sees Q2 revs above consensus, guides FY15 above consensus; PT raised at Stifel, RBC Capital Mkts, DA Davidson, others.
TGI (65.15 +12.11%): Reported Q4 (Mar) earnings of $1.71 per share, excluding non-recurring items, $0.05 better than the Capital IQ Consensus Estimate of $1.66; revenues rose 15.4% year/year to $1.08 bln vs the $1.04 bln consensus.
MOH (64.55 +10.85%): Reported Q1 (Mar) earnings of $0.71 per share, excluding non-recurring items, $0.22 better than the Capital IQ Consensus Estimate of $0.49; revenues rose 53.3% year/year to $3.17 bln vs the $3.11 bln consensus.
Mid Cap Losers
SFM (27.4 -9.3%): Missed Q1 consensus EPS estimates by $0.01, missed on revs; guides FY15 EPS, revs below consensus.
BR (50.81 -6.08%): Missed Q3 (Mar) EPS consensus estimates by $0.05, missed on revs; guided FY15 EPS in-line, revs in-line.
HII (118.1 -4.4%): Downgraded to Mkt Perform from Outperform at Bernstein.
Today's biggest point gainers/losers
Biggest point gainers:
DATA (110.78 +13.35), BIIB (396.22 +12.93), STMP (73.16 +12.49), BLUE (164.07 +11.65), REGN (479.92 +11.30), CF (309.89 +9.80), GOOGL (551.21 +9.17), SYT (85.87 +8.87), GOOG (539.37 +8.67), IMPV (53.52 +8.41), IBB (352.17 +8.06), ACT (294.50 +7.20), NFLX (572.28 +7.04), BIB (164.98 +6.99), AMZN (433.87 +6.99), TGI (64.80 +6.69), AGIO (105.60 +6.47), MOH (64.58 +6.35), CYBR (67.46 +5.99), MHK (184.97 +5.78), OUTR (72.15 +5.68), BOJA (24.59 +5.59), OLED (50.70 +5.50), SPG (188.44 +5.29), EQIX (267.22 +5.22)
Biggest point losers:
MNST (129.43 -14.06), FLDM (27.19 -10.24), HII (117.10 -6.43), ENV (47.01 -5.37), SHAK (62.28 -3.76), PRO (18.15 -3.40), PXD (156.66 -2.91), SFM (27.41 -2.80), MTRX (19.00 -2.53), CERN (68.76 -2.49), SIRO (92.31 -1.99), CRM (72.54 -1.98), SWIR (34.83 -1.98), LNKD (199.50 -1.91), ABMD (67.88 -1.84), BR (52.31 -1.79), ENOC (10.05 -1.68), CBI (47.92 -1.64), BIS (32.02 -1.62), TSLA (235.27 -1.53), NUS (52.49 -1.50), AMBA (71.93 -1.35), GDOT (15.43 -1.29), NVDA (21.25 -1.24), SEMG (82.89 -1.21)
Gapping down
In reaction to disappointing earnings/guidance: AMDA -27.9%, KEYW -21.7%, FLDM -17.2%, PLNR -15.2%, TWOU -14.2%, BEBE -12.3%, BIOS -11.6%, POZN -8.7%, DXPE -8.5%, ABTL -8.4%, UBNT -8.3%, AVNW -7.9%, AVID -7.4%, MDVN -6.7%, MNST -6%, CNCE -5.1%, SPPI -4.9%, PSIX -4.8%, NVDA -4.1%, LIVE -3.5%, JD -3.3%, BBOX -3.1%, CST -3%, NOG -2.9%, CA -2.7%, JAZZ -2.5%, (Concert Pharmaceuticals and Jazz Pharmaceuticals (JAZZ) report results from their Phase 1 clinical study of JZP-386; studies do not support advancing into a later-stage clinical trial of JZP-386 at this time ), EGY -1.9%, TGI -1.9%, UEPS -1.8%, CERN -1.7%, WAIR -1.6%, TESO -1.6%, CROX -1.4%, MACK -1.3%, FATE -1.3%, HZNP -1.3%, CNTY -0.8%, HTGC -0.7%, STON -0.7%, NVAX -0.6%,
M&A news: CRM -3.5% (Microsoft (MSFT) not considering bid for CRM, according to Reuters)
Other news: LJPC -9.7% (announces it will discontinue development of its polysaccharide-based galectin-3 inhibitors, GCS-100 and LJPC-1010), ALDX -6.2% (prices its follow-on public offering of 2,700,000 shares of its common stock at $7.50 per share), CNCE -5.1% (Concert Pharmaceuticals and Jazz Pharmaceuticals (JAZZ) report results from their Phase 1 clinical study of JZP-386; studies do not support advancing into a later-stage clinical trial of JZP-386 at this time ), HMTV -3.1% (prices secondary public offering of ~3.2 mln shares of Class A common stock at $12 per share), CEMP -1.6% (filed mixed securities shelf offering), TSLA -1.2% (small pull back from recent strength), SMLP -0.9% (priced public offering of 6.5 mln common units at $30.75 per unit)
Analyst comments: MHR -1.1% (downgraded to Neutral from Buy at Citigroup), TWO -0.8% (downgraded to Mkt Perform from Outperform at Keefe Bruyette )
Read more: http://www.briefing.com/GeneralContent/Platinum/Active/FullTextSearch/FullTextSearch.aspx#ixzz3ZYK26YJZ
Gapping up
In reaction to strong earnings/guidance: NPTN +26.6%, SEDG +15.6%, IMPV +11.9%, WPRT +10.8%, CALA +10.3%, SSNI +9.8%, PLPM +9.7%, HNSN +8.3%, DATA +7.8%, STMP +7.1%, RMTI +6.9%, VICL +6.7%, XOMA +6.4%, AERI +6.1%, OUTR +5.6%, SAAS +5.5%, FUEL +5.5%, BKD +5.3%, AOL +5%, BITA +4%, MOH +3.9%, NUAN +3.5%, GSAT +3.5%, RLYP +3.5%, CYBR +3.4%, ACAD +3.3%, RYI +3.3%, ACET +3%, BONA +2.9%, RBA +2.9%, SWIR +2.8%, ALSK +2.7%, CPXX +2%, PGH +2%, AIRM +1.9%, TRAK +1.9%, CUTR +1.1%, RGLS +1.1%, GSVC +1.1%, CBS +1%, TRUE +1%, AEZS +1%, KTOS +0.9%, CNAT +0.7%, JMBA +0.5%, ESPR +0.5%, NRG +0.5%
M&A news: SYT +11.2% (reports that co may be acquired by Monsanto (MON) - SYT rejected bid) MCRL +3.7% (Micrel to be acquired by Microchip Technology (MCHP) for $14.00 per share)
Select large pharma related names showing strength: SGEN +3.8%, AZN +3.5%, GSK +3.1%, SHPG +3.1%
Select oil/gas related names showing strength: RDS.A +2.6%, BP +2.2%, TOT +2.1%, SDRL +1.1%, XOM +0.7%
Other news: WLT +27.1% (confirmed last night it will make interest payments, continue discussions with debtholders), GEVO +20.3% (cont strength), MNGA +19% (announces that a major cement company in the U.S. has approved MagneGas fuel to replace acetylene and has placed their first order for a location in Florida), NVGN +14.5% (move being attributed to press release regarding the presentation of positive pre-clinical date for TRXE-009 for the treatment of brain cancer), NDRM +14.2% (announces the FDA has lifted its clinical hold on ND0612 candidates, after a review of additional information related to the product candidates' delivery devices), ICLD +11.3% (announces that its cloud team has been engaged by a large east coast auto parts distributor and wholesaler to design, migrate and implement a cloud solution), SCMP +6.1% (announced that the FDA has granted Fast Track Designation for Cobiprostone, for the prevention of oral mucositis), TOUR +4.9% (announces $500 mln investment from a group of investors), AMRN +3% (discloses lawsuit against the FDA seeking a judicial declaration that an FDA regulation limiting off-label promotion is unconstitutional ), ERIC +2.6% (asserts patents against Apple (AAPL) in Germany, the UK and the Netherlands), NOK +1.3% (seeing reports that Uber has joined in bidding for co's maps unit; bidding up to $3 bln), LYB +1% (announces a new share repurchase agreement for up to 10% of its shares; increases quarterly dividend to $0.78/share from $0.70/share), BIIB +0.8% (announces Board authorization for a $5 bln share repurchase program, in addition to its existing 1.3 mln share authorization )
Analyst comments: ALU +3.8% (upgraded to Buy at UBS), BABA +1.1% (upgraded to Buy from Neutral at Goldman), IVR +1% (upgraded to Outperform from Mkt Perform at Keefe Bruyette), PM +0.8% (upgraded to Neutral from Sell at Goldman)
Read more: http://www.briefing.com/GeneralContent/Platinum/Active/FullTextSearch/FullTextSearch.aspx#ixzz3ZYJpCIvS
S&P futures vs fair value: +14.90. Nasdaq futures vs fair value: +31.40.
The S&P 500 futures trade 15 points above fair value.
April nonfarm payrolls came in at 223,000 while the Briefing.com consensus expected a reading of 218,000. The prior month's reading was revised down to 85,000 from 126,000. Nonfarm private payrolls added 213,000 against the 215,000 expected by the consensus. The unemployment rate fell to 5.4% from 5.5%, which is what the consensus expected.
Hourly earnings rose 0.1% while the consensus expected growth of 0.2%. The average workweek was reported at 34.5, which is what the consensus expected.
OWW bouncing right back up...
Still no fresh news for me...
OWW off a cliff...no news yet...
Notable movers of interest
The following are some of today's most notable movers of interest, categorized by market capitalization (large cap over $10 billion and mid cap between $2-10 billion) and ranked by % change (all stocks over 100K average daily volume).
Large Cap Gainers
QRVO (75.33 +9.08%): Beat Q1 consensus EPS estimates by $0.24, beat on revs; guided Q2 EPS above consensus, revs above consensus; PT raised at Craig Hallum & Ascendiant Capital Markets.
NCLH (52.51 +7.82%): Beat Q1 consensus EPS estimates by $0.04, missed on revs; guided Q2 EPS in-line; raised FY15 EPS guidance.
BABA (85.85 +7.31%): Reported Q4 (Mar) earnings of $0.48 per share, $0.07 better than the Capital IQ Consensus Estimate of $0.41; revenues rose 44.7% year/year to $2.81 bln vs the $2.72 bln consensus; Announced Daniel Zhang as new CEO effective May 10, 2015.
Large Cap Losers
WFM (42.87 -10.17%): Reported Q2 (Mar) EPS in-line, missed on revs; reaffirmed FY15 revs below consensus; Downgraded at BofA/Merrill.
GMCR (99.18 -8.23%): Missed Q2 (Mar) consensus EPS estimates by $0.02, missed on revs; guided Q3 EPS below consensus; lowered FY15 outlook; PT lowered at ROTH Capital.
MT (10.27 -3.2%): Reported Q1 (Mar) loss of $0.41 per share, $0.38 worse than the Capital IQ Consensus Estimate of ($0.03); revenues fell 13.5% year/year to $17.12 bln vs the $16.95 bln consensus.
Mid Cap Gainers
ANAC (62.31 +10.17%): Reported Q1 (Mar) loss of $0.30 per share, $0.16 better than the Capital IQ Consensus Estimate of ($0.46); revenues rose 267.1% year/year to $15.26 mln vs the $9.18 mln consensus; discussed upcoming milestones.
BWC (33.9 +6.37%): Reported Q1 (Mar) earnings of $0.47 per share, $0.04 better than the Capital IQ Consensus Estimate of $0.43; revenues rose 10.4% year/year to $730.57 mln vs the $704.73 mln consensus.
ALB (63.45 +5.75%): Beat Q1 consensus EPS estimates by $0.46, missed on revs; raised FY15 EPS guidance above consensus.
Mid Cap Losers
NUS (51.18 -13.65%): Missed Q1 consensus EPS estimates by $0.01, missed on revs; guided Q2 EPS below consensus, revs below consensus; guided FY15 EPS below consensus, revs below consensus; disclosed SEC investigation regarding certain aspects of Chinese operations.
CPA (94.69 -11.42%): Reported Q1 (Mar) earnings of $2.41 per share, $0.03 better than the Capital IQ Consensus Estimate of $2.38; revenues fell 11.5% year/year to $631.8 mln vs the $640.11 mln consensus; Downgraded at JP Morgan.
THS (73.57 -10.38%): Beat Q1 consensus EPS estimates by $0.01, missed on revs; guided Q2 EPS below consensus; lowered FY15 EPS below consensus.
Today's biggest point gainers/losers
Biggest point gainers:
BLUE (149.93 +10.31), AMZN (426.15 +7.05), QRVO (75.15 +6.09), BABA (86.08 +6.08), QLTY (15.77 +5.97), AVGO (122.55 +5.78), GEVA (209.13 +5.74), ALXN (160.13 +5.12), EQIX (263.25 +4.97), ACT (288.20 +4.89), HUBS (45.12 +4.87), ALB (64.29 +4.29), RGEN (36.12 +4.14), GOOG (528.20 +3.98), GOOGL (538.88 +3.80), PANW (149.19 +3.39), CELG (111.89 +3.24), BDX (144.11 +3.03), TEGP (31.99 +2.99), VC (104.75 +2.77), MMS (65.74 +2.75), ANN (40.09 +2.73), ETE (68.09 +2.54), VECO (30.76 +2.51), OVAS (27.00 +2.51)
Biggest point losers:
CPA (95.16 -11.74), THS (71.71 -10.38), HII (124.04 -9.69), GMCR (98.47 -9.61), NUS (51.09 -8.18), MELI (142.36 -6.15), VRNS (21.37 -5.31), LCI (55.30 -5.02), WFM (42.71 -5.01), EPAM (61.67 -4.74), SHAK (70.80 -4.33), TDC (40.62 -4.32), WCG (77.08 -3.89), PXD (156.06 -3.84), ABMD (70.03 -3.81), CXO (116.42 -3.68), TUMI (20.07 -3.34), SM (53.70 -2.91), UNT (33.05 -2.77), PDCE (51.13 -2.75), CCOI (32.74 -2.73), FLTX (41.95 -2.71), ANTM (157.16 -2.69), KATE (29.92 -2.64), APA (64.70 -2.64)
Gapping down
In reaction to disappointing earnings/guidance: NUS -19.7%, VRNS -15.7%, TUMI -14.5%, WFM -13.9%, NSIT -11.2%, GMCR -10.7%, MCP -10.4%, FRSH -10.1%, (files for ~7.92 mln share common stock offering by selling shareholders ), ENVA -9.6%, LCI -9.5%, FLTX -8.4%, TTPH -7.5%, CPA -7.3%, RDEN -6.8%, MTDR -6.3%, SN -5.1%, RESI -5%, QTM -4.8%, (also announces resignation of Jeffrey Smith from its board of directors and appointment of Robert Andersen pursuant to Starboard's replacement rights ), APO -4.8%, CRIS -4.6%, BREW -4.5%, SZYM -4.5%, SMLP -4.3%, (also announces a 6.5 mln common unit public offering), RWLK -4.2%, WRES -3.8%, TDC -3.8%, AGIO -3.7%, ALDW -3.4%, SD -3.4%, CODI -3.1%, TSLA -2.8%, SEAS -2.5%, FSYS -2.3%, MWW -1.9%, EVTC -1.7%, SPH -1.7%, ATVI -1.6%, SQNM -1.6%, PMT -1.6%, PTLA -1.5%, EXTR -1.5%, FIG -1.5%, MATR -1.4%, RST -1.3%, EFC -1.3%, CSLT -1.1%, MRO -1%, AG -1%, RRD -1%, WAC -0.9%, MET -0.7%, AREX -0.7%, CZR -0.6%
Select metals/mining showing early weakness: HMY -6%, AU -5%, BHP -3%, RIO -2.5%
Other news: AFMD -4.8% (prices 5,000,000 of common shares at $7.15 per common share), GSK -3.1% (still checking), CSIQ -2.7% (signs $250 mln loan agreement with China Minsheng Bank), VRSK -2.7% (prices 9,640,000 shares of its Class A common stock at $70.00 per share), DDD -1.7% (still checking), FCE.A -1.3% (prices 32.5 million shares of Class A common stock at $22.50 per share), LL -1.0% (CNBC reporting that the company plans to halt sales of laminate flooring made in China)
Analyst comments: TASR -3.2% (downgraded to Perform from Outperform at Oppenheimer), BONA -2.7% (downgraded to Underperform at BofA/Merrill).
Read more: http://www.briefing.com/GeneralContent/Platinum/Active/FullTextSearch/FullTextSearch.aspx#ixzz3ZSSEGrEB
Gapping up
In reaction to strong earnings/guidance: BEAT +12%, BIOD +11.5%, HRTG +11.5%, QRVO +11.5%, HRTG +11.5%, BABA +10.4%, CHGG +9.2%, TA +8.8%, EMKR +8.1%, (also Announces That It Intends To Commence A Dutch Auction Tender Offer For Up To Approximately $45 Million of Common Stock), ENSG +7.2%, ATML +6.8%, ZNGA +6.1%, CBB +5.4%, CSOD +5.2%, TRIP +4.8%, SUNE +4.5%, MASI +4.4%, GOGO +3.4%, TAP +2.9%, CPE +2.7%, LXP +2.7%, PSEC +2.4%, BLUE +2.4%, CTIC +2.3%, DYN +2%, (also amends employment agreement with CEO Robert Flexon), HUBS +1.9%, COTY +1.8%, TOWR +1.8%, IVR +1.6%, TKMR +1.2%, TWO +1%, KIM +0.9%, CLR +0.9%, PRU +0.8%, VVC +0.8%, PDLI +0.6%
M&A news: QLTY +61.4% (agrees to be acquired by Funds Advised by Apax Partners for $16.00 per share in all cash), ANN +8.7% (Reuters reporting in talks with Golden Gate)
Other news: YHOO +7% (trading higher with BABA), ANY +6.5% (reported award of two patents for Peer-to-Peer Redundant File Server System and Methods), GST +5.6% (enters into agreement to sell certain non-core assets in Oklahoma for ~$46.2 mln, with the transaction expected to close on or before June 22, 2015), NBG +5% (cont volatility with Greece), EQIX +1.8% (issues response to announcement by TelecityGroup), NBY +1.5% (announces the presentation of new research documenting the successful use of Avenova on patients with blepharitis ), QTM +1.4% (announced resignation of Jeffrey Smith from its board of directors and appointment of Robert Andersen pursuant to Starboard's replacement rights)
Analyst comments: ZQK +3% (upgraded to Buy from Neutral at B. Riley & Co ), TNXP +2% (initiated with a Buy at Janney), INFI +1.2% (initiated with a Buy at Deutsche Bank), DKS +0.9% (upgraded to Outperform from Market Perform at BMO Capital)
Read more: http://www.briefing.com/GeneralContent/Platinum/Active/FullTextSearch/FullTextSearch.aspx#ixzz3ZSRvCaB7
Y'all have good evening...the market should be interesting yet again...
:)
AXLL down a bit as well...here is an article...
Same Store Sales come out tomorrow morning...
Earnings Calendar
Today after the close look for the following companies to report:
ALB, EXTR, QTM, ATO, JKHY, ATML, BGC, EPM, ESS, FGL, FOXA, GMCR, LCI, OSUR, PFSI, PMT, PNNT, PRU, PSEC, TWO, WGL, ATVI, KIM, MRIN, NUS, SLH, GBDC, ENSG, EXXI, NEWP, PRI, PAYC, CJES, CPA, CSOD, CXW, EFC, HIVE, HUBS, IO, MET, NSIT, REG, SWM, TRIP, TSLA, WFM, CUZ, EGN, GUID, RYN, VVC, CF, HR, MASI, NP, PHH, VECO, VRNS, AMTG, CSLT, EQC, ETE, ETP, EVTC, LDRH, MRO, PRAH, SUN, SXL, THRX, AUQ, BEAT, BRKR, FNGN, VNDA, XNPT, CBPX, CHGG, IVR, PDLI, ACAS, AWK, BNFT, CLR, DPM, FLTX, NLY, NSTG, ORA, WBMD, AREX, BWC, CHEF, CLVS, EPAM, IL, KW, LGCY, LHCG, MCHX, MELI, OAS, PGTI, QLTY, RIG, RIGP, RLJ, SBY, KND, MITT, PEGA, PFMT, REXR, SD, SGM, SZYM, TUMI, XENT, CODI, CZR, FOXF, MTDR, PRAA, PTLA, SN, TCAP, CECO, ALDW, BREW, CCRN, CPE, ECR, HRTG, JONE, SQNM, TROX, WTI, CKP, DMD, LADR, TTPH, MYRG, RST, ANAC, NEFF, FRSH, KTWO, FNV, INOV, KRNT, JRVR
Tomorrow before the open look for the following companies to report:
BABA, CHD, NJR, STE, APO, BDX, COTY, DFT, IT, LIOX, LQDT, MMS, NICE, PMFG, PPL, RDEN, RFP, RSTI, SPH, TDC, ALU, FELP, GOLD, TLM, CDW, GSM, MWW, REGN, TAP, WPP, APA, MFC, MPEL, MPW, MT, NRP, OWW, RWLK, SNI, SSTK, THS, TIME, TOWR, TU, AGIO, ALE, NCLH, USAC, CNK, CONE, ENZY, HL, MZOR, SUNE, ARIA, CBB, CCC, DWRE, GTS, HII, IRC, LXP, PCLN, PDCE, ROCK, SATS, DNOW, COT, CRIS, MGA, WIN, AEE, CCOI, RRD, BDBD, CNSL, FIG, GOGO, HMHC, IPCC, LPI, MITL, NXST, OGE, ONE, SEAS, SFY, SNAK, SRPT, VC, WAC, WPG, AAON, HPT, SRI, CORE, PMC, RESI, INSY, KATE, AXAS, DOC, GSIG, INXN, ACHN, ACRE, AMRC, CECE, CNQ, CSIQ, HILL, ICD, PRFT, USPH, VTG, NNBR, BLT, FSYS, WRES, GLP, HWCC, LCUT, LEAF, LGIH, PGEM, RICE, RMP, TLP, RGEN, TA, KVHI, ARCP
Notable Movers of Interest
The following are some of today's most notable movers of interest, categorized by market capitalization (large cap over $10 billion and mid cap between $2-10 billion) and ranked by % change (all stocks over 100K average daily volume).
Large Cap Gainers
BMRN (119.74 +5.11%): Outperforming in sympathy after peer Synageva Biopharma (GEVA) announced it was being acquired for $8.4 bln.
RCI (36.24 +3.9%): Upgraded to Outperform at Scotia Capital.
AGU (107.19 +3.46%): Missed Q1 consensus EPS estimates by $0.20, missed on revs; guided FY15 EPS in-line; announced dividend increase of 12%.
Large Cap Losers
ALXN (152 -9.82%): Announced it will acquire Synageva Biopharma (GEVA) in $8.4 bln deal, or $230 per share in cash and stock, a 140% premium to yesterday's close.
CHK (14.96 -5.71%): Reported Q1 (Mar) earnings of $0.11 per share, excluding non-recurring items, $0.07 better than the Capital IQ Consensus Estimate of $0.04; revenues fell 45.3% year/year to $2.76 bln vs the $3.45 bln consensus; Downgraded to Underperform at Jefferies, PT $12.
OKE (45.15 -5.85%): Reports Q1 (Mar) earnings of $0.29 per share, $0.06 worse than the Capital IQ Consensus Estimate of $0.35.
Mid Cap Gainers
GEVA (204.81 +113.63%): Being acquired by Alexion Pharmaceuticals (ALXN) for consideration of $115 in cash and 0.6581 ALXN shares, implying a total per share value of $230 in $8.4 bln deal, net of cash.
HLF (48.49 +20.95%): Beat Q1 consensus EPS estimates by $0.28, beat on revs; guided Q2 EPS just above consensus, revs in-line; raised FY15 EPS above consensus, lowered rev slightly, in-line; PT raised at Canaccord Genuity.
WEN (11.06 +5.99%): Beat Q1 consensus EPS estimates by $0.01, missed on revs; reaffirmed FY15 guidance, announced its intention to refinance its existing senior secured credit facility.
Mid Cap Losers
FTR (6.09 -9.64%): Reported Q1 (Mar) earnings of $0.02 per share, excluding non-recurring items, $0.02 worse than the Capital IQ Consensus Estimate of $0.04; revenues rose 18.8% year/year to $1.37 bln vs the $1.39 bln consensus.
GRPN (6.33 -7.46%): Beat Q1 consensus EPS estimates by $0.01, missed on revs; guided Q2 EPS in-line, revs below consensus; guided FY15 revs in-line.
NWSA (14.94 -6.74%): Reported Q1 (Mar) earnings of $0.05 per share, excluding non-recurring items, $0.02 worse than the Capital IQ Consensus Estimate of $0.07; revenues fell 0.8% year/year to $2.06 bln vs the $2.12 bln consensus.
WU unhalted...dropped about a dollar on this
WU halted for news...might be a merger with MGI?? Speculation going on...
Kale on the menu at McDonalds? Guess we had better load the boat...LOL
http://www.bloomberg.com/news/articles/2015-05-06/kale-is-headed-to-mcdonald-s-salads-in-canada-analyst-reports
Today's biggest point gainers/losers
Biggest point gainers:
GEVA (205.97 +110.10), REGN (476.22 +10.72), BRDR (13.92 +7.13), HLF (46.05 +5.96), BMRN (119.53 +5.61), RARE (68.02 +5.39), PTBI (10.55 +4.58), ESPR (100.81 +3.81), BLUE (136.54 +3.48), KITE (57.25 +3.48), AGU (106.95 +3.34), PLCE (65.43 +3.19), WD (22.65 +3.06), IBB (340.99 +2.99), FISV (80.47 +2.99), CRAY (30.81 +2.98), PTCT (56.00 +2.87), BUD (120.06 +2.86), BIB (155.00 +2.55), QURE (27.20 +2.50), PZZA (64.01 +2.48), NLNK (49.35 +2.33), ISIS (60.59 +2.25), EA (61.40 +2.24), LAMR (59.59 +2.18)
Biggest point losers:
ALXN (153.47 -15.08), FOSL (77.32 -9.14), TNET (29.25 -5.18), ICE (228.18 -3.99), BWLD (153.00 -3.99), BIDU (190.94 -3.80), NDLS (16.95 -3.76), WLKP (22.19 -3.70), AXLL (35.97 -3.60), WAGE (47.37 -3.29), VSI (39.04 -3.27), NFLX (562.59 -2.96), HAIN (58.40 -2.86), ALL (67.20 -2.80), ATHM (50.09 -2.73), OKE (45.38 -2.57), ACT (283.26 -2.49), ABMD (73.15 -2.32), AMZN (419.09 -2.10), QIHU (54.30 -2.00), ACHC (66.10 -1.90), TSLA (231.18 -1.77), EXAM (40.23 -1.76), MPC (100.10 -1.73), SHPG (237.46 -1.73)
Read more: http://www.briefing.com/Platinum/InDepth/InPlay.htm#ixzz3ZNHCRSjt
Gapping down
In reaction to disappointing earnings/guidance: ANAD -24.6%, NDLS -22.3%, ZU -20.1%, TTGT -13%, SKUL -11.8%, TNET -8.5%, TRUP -7.6%, VSI -6.6%, EVOL -6.1%, ENPH -5.8%, OCLR -5.3%, ATRS -4.3%, CERS -3.8%, RUBI -3.6%, CRNT -2.9%, NFX -2.7%, NWPX -2.6%, SM -2.6%, CTLT -2.3%, MIFI -2.1%, CLMT -2.1%, NYMT -2%, SAFT -1.9%, XXIA -1.9%, MYGN -1.6%, SUPN -1.6%, KGC -1.6%, AGU -1.6%, SODA -1.6%, GRPN -1.5%, SAND -1.5%, SCMP -1.4%, DDD -1.2%, WTW -1.1%, CLH -1%, SLRC -0.9%, CLUB -0.9%, AVA -0.9%, MPO -0.9%, PAA -0.8%
M&A news: ALXN -3.7% (acquired GEVA for consideration of $115 in cash and 0.6581 ALXNshares)
Other news: ARDX -26.7% (announces results from its Phase 2a clinical trial evaluating Tenapanor in Chronic Kidney disease patients; trial did not meet the primary endpoint of decreasing the urinary albumin-creatinine ratio in treated patients ), WLT -17.4% (discussed Going concern issues in 10-Q), ATRS -4.3% ( announces proposed public offering of common stock), ANTM -2.1% (announces a proposed public offering of $900 mln in equity units; units issued at $50/unit will consist of contract to purchase on share of common stock in the future and an interest in subordinated notes ), ACHC -2% (priced 4.5 mln share public offering of common stock at $66.50 per share)
Analyst comments: ENPH -5.8% (downgraded to Underperform from Neutral at BofA/Merrill), WSH -2.2% (downgraded to Sell from Neutral at Goldman), CTB -1.7% (downgraded to Sell from Neutral at Goldman), AMTD -0.9% (downgraded to Neutral from Buy at BofA/Merrill)
Read more: http://www.briefing.com/GeneralContent/Platinum/Active/FullTextSearch/FullTextSearch.aspx#ixzz3ZMXUG28h
Gapping up
In reaction to strong earnings/guidance: HLF +15.6%, JNP +12.7%, PACB +12.3%, ( achieves second development milestone in clinical diagnostics agreement with Roche (RHHBY); $10 mln milestone payment brings total funding to date from RHHBY up to $55 Million), KOPN +12.1%, ICUI +11.6%, ACLS +10%, AXTA +9.7%, ZEN +9.4%, ZAGG +8%, WD +7.2%, FOLD +7%, LC +6.7%, POWR +6.5%, WIX +6.4%, PZZA +6.3%, CMLP +6.3%, MM +5.6%, QNST +5.1%, WPX +5%, EA +4.8%, STEM +4.7%, TXMD +4.4%, CSTE +4.1%, CYH +3.8%, VRNG +3.6%, ATHM +3.5%, RCPT +3.4%, REXX +2.6%, EXAM +2.4%, GDP +2%, ZLTQ +1.9%, PERI +1.9%, TSRA +1.5%, COUP +1.4%, EGAN +1.4%, DVN +1.3%, CHK +1.3%, QGEN +1.1%, HFC +1%, ARP +1%
M&A news: GEVA +130.8% (to be acquired by Alexion Pharmaceuticals (ALXN) for consideration of $115 in cash and 0.6581 ALXN shares, implying a total per share value of $230 in $8.4 bln deal), BRDR +105% (Borderfree to be acquired by Pitney Bowes (PBI) for $14.00 per share in cash or ~$395 mln ), PTBI +35.8% (announces agreement to acquires Abeona Therapeutics for ~3.98 mln PTBI common stock shares and up to $9 mln in performance milestones), MGI +23.2% (seeing reports that Western Union (WU) is in early talks to acquire the company), PLCE +1.4% (has hired bankers to consider sale amid activist pressure, according to NY Post), CRM +1.4% (following late move higher on MSFT bid speculation)
Select EU financial related names showing strength: NBG +5.5% (reported progress in Greek negotiations), DB +1.7%, SAN +1.6%, HSBC +1.4%
Select oil/gas related names showing strength: SDRL +4.3%, RIG +1.9%, PBR +1.2%
Other news: FATE +82.7% (Juno and Fate Therapeutics (FATE) announce a strategic research collaboration regarding Juno's genetically-engineered T cell product candidates; includes a Juno purchase of FATE stock), LOCM +13.6% (disclosed amendment to Google Services Agreement ), PACB +12.3% (achieved second development milestone in clinical diagnostics agreement with Roche (RHHBY); $10 mln milestone payment brings total funding to date from RHHBY up to $55 mln), CYTX +5.6% (confirmed FDA Orphan Drug Designation for RE-024 for the treatment of Pantothenate Kinase-Associated Neurodegeneration), RTRX +4.3% (confirmed FDA Orphan Drug Designation for RE-024 for the treatment of Pantothenate Kinase-Associated Neurodegeneration), NOK +3.6% (rebounding form yday), BMRN +3.6% (in symp with GEVA M&A news), DDD +3.3% (entered into a reseller agreement with HK 3D, a supplier of 3D printers and additive manufacturing in the UK and Ireland), ALU +3.2% (rebounding form yday), ARIA +3.2% (announced that ARIAD has granted Gen Ilac exclusive rights to distribute Iclusig in Turkey, for patients with Philadelphia-positive leukemias), JUNO +2.8% (Juno and Fate Therapeutics (FATE) announce a strategic research collaboration regarding Juno's genetically-engineered T cell product candidates; includes a Juno purchase of FATE stock), ONCY +2.7% (confirms receipt of Orphan Drug Designation from the FDA for Reolysin, to treat gastric cancers), MYCC +2.5% (prices 12,000,000 shares of its common stock at $20.75 per share by selling shareholders), GWPH +2.2% (announces the initiation of a Phase 2 clinical study of Cannabidivarin to treat Epilepsy), HQY +1.4% (prices 3,850,000 shares of common stock at $25.90 per share; shares sold by co and selling shareholders)
Analyst comments: SRPT +5.1% (upgraded to Outperform at Robert W. Baird), ITCI +4.9% (initiated with a Buy at Sun Trust Rbsn Humphrey; tgt $50), YNDX +2.5% (upgraded to Buy from Neutral at UBS), SCHW +1.6% (upgraded to Buy from Neutral at BofA/Merrill), AXP +1.2% (upgraded to Outperform from Mkt Perform at Bernstein), GLMD +0.8% (initiated with a Buy at Sun Trust Rbsn Humphrey)
Read more: http://www.briefing.com/GeneralContent/Platinum/Active/FullTextSearch/FullTextSearch.aspx#ixzz3ZMXDAAeN
Just FYI, conix...
Earnings Calendar...so many still reporting...wow...
Today after the close look for the following companies to report:
IGTE, EA, QGEN, WSTC, CENT, FISV, MYGN, OCLR, PACB, POWL, QNST, RNR, SPA, ALL, CSGS, PAA, PAGP, ACLS, COUP, ESE, ICUI, ANDE, GHDX, JIVE, KGC, PXD, RLOC, TMH, TSRA, USNA, CRAY, CTL, CTLT, SLF, TTGT, ZEN, ZU, AIZ, DLR, GRPN, IRWD, WAGE, ANAD, BRDR, DVN, ENPH, FOSL, KAR, PBPB, TTOO, AXLL, CVG, DTLK, EXAM, IAG, MHLD, PKD, REXX, SBRA, SCTY, WES, WGP, CYH, FTR, NDLS, DK, DKL, OKE, OKS, QUAD, AGU, AMRS, ARC, GNMK, KONA, LC, NFX, NYMT, PZZA, RUBI, SM, TRNX, VVUS, XXIA, Y, ZAGG, AMSG, AWR, CLUB, GMED, GPOR, HK, TEG, WR, BIO, CERS, CSU, HLF, OUT, RP, WSR, WTR, WTW, MYL, PCTI, CDI, REGI, TNET, TRIV, ZLTQ, LMOS, TSE, ATSG, SKUL, MM, ERA, GCA, HRZN, SUPN, NWPX, NVGS, WG
Tomorrow before the open look for the following companies to report:
KELYA, OXY, CKSW, HCLP, HAIN, LG, MSI, SE, TMHC, CRRC, EGAN, STRA, IMN, WIX, CSTE, VOYA, WCG, VG, WD, BAM, HTA, NOR, SBGI, XRAY, AYR, DAVE, DNR, ENB, CHH, SWC, TVPT, CEQP, CMLP, CRNT, CRZO, INFI, SPNS, TRXC, VSI, WEN, AVA, CHK, CLH, EE, HFC, LAMR, MEMP, MWE, PERI, SODA, WPX, ANSS, BUD, DDD, HSC, HSNI, NXTM, RHP, SNH, GDP, GLOG, RDC, WMC, XLS, ATHM, AVOL, FSTR, ARQL, POWR, SCMP, EXK, LINC, RDUS, SUP, MPO, PGNX
Read more: http://www.briefing.com/Platinum/InDepth/InPlay.htm#ixzz3ZIJHDM7x
Notable movers of interest :
The following are some of today's most notable movers of interest, categorized by market capitalization (large cap over $10 billion and mid cap between $2-10 billion) and ranked by % change (all stocks over 100K average daily volume).
Large Cap Gainers
EL (87.92 +5.24%): Beat Q3 (Mar) consensus EPS estimates by $0.21, beat on revs; guided FY15 EPS above consensus, revs in-line .
UBS (21.44 +5.31%): Reported Q1 EPS of CHF0.53 vs CHF0.33 Capital IQ consensus; Combined wealth management businesses adjusted profit before tax CHF 1.1 billion, the highest since 2008.
MNK (121.37 +5.54%): Beat Q2 (Mar) consensuses EPS estimates by $0.20, beat on revs; raised FY15 guidance.
Large Cap Losers
IP (51.63 -3.93%): Under pressure following potential new IRS rules on MLP's.
BIDU (195.24 -4.15%): Downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $215 from $240; also under pressure after China's Shanghai exchange drops 4%.
SRE (104.49 -3.08%): Beat Q1 consensus EPS estimates by $0.39, missed on revs; reaffirmed FY15 EPS guidance.
Mid Cap Gainers
GLNG (47.63 +26.54%): Announced that it has signed a binding Heads of Terms with Ophir Energy Plc for the provision of the GoFLNG vessel Gimi; agreement will be structured as a 20-year tolling contract; also has commenced discussions with partners Keppel and Black & Veatch aimed at exercising an option for the ordering of a third GoFLNG unit similar to the Hilli and the Gimi.
ABMD (75.18 +15.41%): Reported Q4 (Mar) results, beat on revs; raised FY16 rev guidance above consensus.
KMT (38.75 +7.22%): Beat Q3 (Mar) consensus EPS estimates by $0.03, reported revs in-line; guided FY15 EPS in-line, Lowered FY15 revenue outlook.
Mid Cap Losers
NSM (20.01 -23.54%): Reported Q1 (Mar) loss of $0.53 per share, $1.24 worse than the Capital IQ Consensus Estimate of $0.71; revenues fell 15.0% year/year to $382.11 mln vs the $501.93 mln consensus.
PBYI (172.75 -10.49%): Downgraded to Market Perform from Outperform at Cowen.
MUSA (61.49 -7.18%): Reports Q1 (Mar) earnings of $0.50 per share, $0.01 better than the Capital IQ Consensus Estimate of $0.49; revenues fell 28.6% year/year to $3 bln vs the $3.94 bln Capital IQ consensus.
INVN Yes, I definitely agree...
Today's biggest point gainers/losers
Biggest point gainers:
NFLX (575.22 +20.32), GLNG (47.53 +9.89), ABMD (74.14 +9.00), EL (88.15 +4.61), CHUY (26.47 +4.32), MNK (119.05 +4.05), TDW (30.68 +3.40), KEX (82.73 +3.27), TSLA (233.73 +3.22), NLS (20.26 +3.05), AMAG (56.80 +2.82), ENR (141.99 +2.79), DO (35.88 +2.78), MIC (84.89 +2.75), ICE (229.25 +2.66), SALE (19.84 +2.63), KMT (38.70 +2.56), EMES (40.42 +2.24), SAFM (80.18 +2.16), HP (79.57 +2.06), ATW (34.94 +1.90), URI (100.87 +1.85), HOS (24.22 +1.81), EMN (80.44 +1.78), NLNK (46.37 +1.71)
Biggest point losers:
QLYS (39.34 -15.74), BIDU (194.78 -8.92), GOOG (532.14 -8.64), GOOGL (545.53 -7.32), PTCT (53.81 -7.03), SCOR (44.78 -6.76), IBB (338.71 -6.48), NSM (20.22 -5.96), SHPG (238.14 -5.89), ANIP (56.16 -5.66), BIB (153.60 -5.25), CP (190.32 -5.12), TDG (215.43 -4.85), VRTX (121.72 -4.58), MUSA (61.93 -4.32), TQQQ (108.77 -4.31), SRE (103.56 -4.25), PANW (148.80 -3.97), AVGO (117.43 -3.73), ILMN (185.92 -3.73), ELLI (61.06 -3.59), VRX (219.38 -3.48), EW (124.35 -3.40), QIHU (58.03 -3.36), SWKS (95.78 -3.33)
Read more: http://www.briefing.com/Platinum/InDepth/InPlay.htm#ixzz3ZHMJ6Ucq
Be back in a little while...errands to run...later guys..
CLNE is bashed...(at least a bit) Clean Energy Fuels trading lower by 0.9%: Street Sweeper out with a cautious report on CLNE (9.45 -0.08)
StreetSweeper Report
http://thestreetsweeper.org/
INVN...covered all...now I can just whine about what I left on the table and why I did not get a piece of this long somewhere around 10:05 AM or so, then sold that position at the peak and then shorted the climactic top...
Live and learn (again and again)..just b/c they gap down nicely doesn't at all mean that's the direction they'll continue...
Noticed a large short position on this one too...